These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4591987)

  • 21. [Effect of oxandrolone on body height and skeletal maturation in some growth disorders in children].
    Rybakowa M; Król W; Krzyzanowska T
    Pediatr Pol; 1975 Jun; 50(6):735-43. PubMed ID: 1134870
    [No Abstract]   [Full Text] [Related]  

  • 22. Growth hormone therapy in Turner's syndrome: an update on final height. Genentech National Cooperative Study Group.
    Rosenfeld RG
    Acta Paediatr Suppl; 1992 Sep; 383():3-6; discussion 7. PubMed ID: 1458013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxandrolone in constitutional delay of growth: analysis of the growth patterns up to final stature.
    Bassi F; Neri AS; Gheri RG; Cheli D; Serio M
    J Endocrinol Invest; 1993 Feb; 16(2):133-7. PubMed ID: 8463549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is the value of growth hormone treatment in short children with specified syndrome? Turner's syndrome, osteochondrodysplasias, Prader-Willi syndrome, Noonan syndrome.
    Nilsson KO
    Acta Paediatr Scand Suppl; 1989; 362():61-8. PubMed ID: 2485602
    [No Abstract]   [Full Text] [Related]  

  • 25. Oxandrolone treatment of constitutional short stature in boys during adolescence: effect on linear growth, bone age, pubic hair, and testicular development.
    Marti-Henneberg C; Niirianen AK; Rappaport R
    J Pediatr; 1975 May; 86(5):783-8. PubMed ID: 1133662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth hormone therapy in Turner syndrome.
    Davenport ML
    Pediatr Endocrinol Rev; 2012 May; 9 Suppl 2():723-4. PubMed ID: 22946284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies of anabolic steroids: v. effect of prolonged oxandrolone administration on growth in children and adolescents with uncomplicated short stature.
    Moore DC; Tattoni DS; Limbeck GA; Ruvelcaba RH; Lindner DS; Gareis FJ; Al-Agba S; Kelley VC
    Pediatrics; 1976 Sep; 58(3):412-22. PubMed ID: 183178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Partial growth hormone deficiency: endogenous growth hormone content and effect of exogenously administered human growth hormone].
    Butenandt O
    Klin Wochenschr; 1973 Mar; 51(6):266-71. PubMed ID: 4698393
    [No Abstract]   [Full Text] [Related]  

  • 29. Carbohydrate and lipid metabolism in Turner syndrome: effect of therapy with growth hormone, oxandrolone, and a combination of both.
    Wilson DM; Frane JW; Sherman B; Johanson AJ; Hintz RL; Rosenfeld RG
    J Pediatr; 1988 Feb; 112(2):210-7. PubMed ID: 3276862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of anabolic agents in treatment of short children.
    Kelley VC; Ruvalcaba RH
    Clin Endocrinol Metab; 1982 Mar; 11(1):25-39. PubMed ID: 7094391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolated growth hormone deficiency in prepubertal children. Influence of human growth hormone on longitudinal growth, adipose tissue, bone mass and bone maturation.
    Ferrandez A; Zachmann M; Prader A; Illig R
    Helv Paediatr Acta; 1970 Dec; 25(6):566-76. PubMed ID: 5515940
    [No Abstract]   [Full Text] [Related]  

  • 32. Growth and metabolic consequences of growth hormone treatment in prepubertal short normal children.
    McCaughey ES; Mulligan J; Voss LD; Betts PR
    Arch Dis Child; 1994 Sep; 71(3):201-6. PubMed ID: 7979491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxandrolone effect on growth and bone age in idiopathic growth failure.
    Geller J
    Acta Endocrinol (Copenh); 1968 Oct; 59(2):307-16. PubMed ID: 4301813
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of combined treatment with growth hormone and gonadotropin releasing hormone analogue in children with poor prognosis of adult height.
    Toumba M; Bacopoulou I; Savva SC; Skordis N
    Indian Pediatr; 2007 Jul; 44(7):497-502. PubMed ID: 17684302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone.
    Cara JF; Kreiter ML; Rosenfield RL
    J Pediatr; 1992 May; 120(5):709-15. PubMed ID: 1533661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of the secretion and metabolic effects of human growth hormone in children with glucocorticoid-induced growth retardation.
    Root AW; Bongiovanni AM; Eberlein WR
    J Pediatr; 1969 Nov; 75(5):826-32. PubMed ID: 5347432
    [No Abstract]   [Full Text] [Related]  

  • 37. Three-year results of a randomized prospective trial of methionyl human growth hormone and oxandrolone in Turner syndrome.
    Rosenfeld RG; Hintz RL; Johanson AJ; Sherman B; Brasel JA; Burstein S; Chernausek S; Compton P; Frane J; Gotlin RW
    J Pediatr; 1988 Aug; 113(2):393-400. PubMed ID: 3397807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acceleration of growth in Turner syndrome patients treated with growth hormone: summary of three-year results.
    Rosenfeld RG
    J Endocrinol Invest; 1989; 12(8 Suppl 3):49-51. PubMed ID: 2681348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole body nitrogen kinetics and their relationship to growth in short children treated with recombinant human growth hormone.
    Dempsher DP; Bier DM; Tollefsen SE; Rotwein PS; Daughaday WH; Jensen MC; Galgani JP; Heath-Monnig E; Trivedi B
    Pediatr Res; 1990 Oct; 28(4):394-400. PubMed ID: 2235139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of constitutional growth delay in prepubertal boys with a prolonged course of low dose oxandrolone.
    Papadimitriou A; Wacharasindhu S; Pearl K; Preece MA; Stanhope R
    Arch Dis Child; 1991 Jul; 66(7):841-3. PubMed ID: 1863096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.